Renaissance Technologies LLC 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 2:26 pm Purchase | 2025-09-08 | 13G | Collegium Pharmaceutical, Inc. COLL | Renaissance Technologies LLC | 1,599,189 5.060% | 78,019 (+5.13%) | Filing |
| 2025-08-13 4:05 pm Sale | 2025-04-01 | 13G | Collegium Pharmaceutical, Inc. COLL | Renaissance Technologies LLC | 1,521,170 4.820% | -134,899 (-8.15%) | Filing |
| 2024-11-13 2:39 pm Purchase | 2024-08-02 | 13G | Collegium Pharmaceutical, Inc. COLL | Renaissance Technologies LLC | 1,656,069 5.140% | 1,656,069 (New Position) | Filing |